Triglyceride-lowering therapies in hypertriglyceridemia-associated acute pancreatitis in China: a multicentre prospective cohort study
Authors:
Open Access
- 15 November 2024
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 22 (1) , 1-11
Abstract
No specific triglyceride-lowering therapy is recommended in patients with hypertriglyceridemia-associated acute pancreatitis (HTG-AP), primarily because of the lack of quality evidence. This study aimed to describe practice variations in triglyceride-lowering therapies for early HTG-AP patients and assess whether more rapid triglyceride decline is associated with improving organ failure. This is a multicentre, prospective cohort study recruiting HTG-AP patients with elevated plasma triglyceride (> 11.3 mmol/L) admitted within 72 h from the onset of symptoms. Patients were dichotomised on study day 3 into either target reaching (plasma triglyceride ≤ 5.65 mmol/L) or not. The primary outcome was organ failure-free days (OFFD) to 14 days of enrolment. The association between target-reaching and OFFD was modelled. Additionally, the slope in plasma triglyceride over the first three days in response to treatment was calculated, and its association with OFFD was assessed as a sensitivity analysis. Among the 300 enrolled patients, 211 underwent exclusive medical treatment, and 89 underwent various blood purification therapies. Triglyceride levels were available in 230 patients on study day 3, among whom 122 (53.0%) had triglyceride levels of ≤ 5.65 mmol/l. The OFFD was not different between these patients and those in whom plasma triglyceride remained > 5.65 mmol/L [median (IQR): 13 (10–14) vs. 14 (10–14), p = 0.46], even after adjustment for potential confounders. For the decline slopes, there was no significant change in OFFD with a steeper decline slope [risk difference, − 0.088, 95% CI, − 0.334 to 0.158, p = 0.48]. Triglyceride-lowering therapies vary greatly across centres. More rapid triglyceride decline was not associated with improving incidence and duration of organ failure.Keywords
This publication has 36 references indexed in Scilit:
- Early Plasmapheresis Among Patients With Hypertriglyceridemia–Associated Acute PancreatitisJAMA Network Open, 2023
- Effect of Low-Normal vs High-Normal Oxygenation Targets on Organ Dysfunction in Critically Ill PatientsJAMA, 2021
- Hypertriglyceridemia is often under recognized as an aetiologic risk factor for acute pancreatitis: A population-based cohort studyPancreatology, 2021
- Potential differences between double-filtration plasmapheresis and therapeutic plasma exchange in the treatment of acute hypertriglyceridemic pancreatitisJournal of Clinical Apheresis, 2021
- Clinical features of hypertriglyceridemia-induced acute pancreatitis in an international, multicenter, prospective cohort (APPRENTICE consortium)Pancreatology, 2020
- Worldwide Variations in Demographics, Management, and Outcomes of Acute PancreatitisClinical Gastroenterology and Hepatology, 2019
- A systematic review of the epidemiology, pathophysiology and current management of hyperlipidaemic pancreatitisClinical Nutrition, 2018
- Pre-morbid glycemic control modifies the interaction between acute hypoglycemia and mortalityIntensive Care Medicine, 2016
- Elevated Serum Triglycerides are Independently Associated With Persistent Organ Failure in Acute PancreatitisAmerican Journal of Gastroenterology, 2015
- Ethanol toxicity in pancreatic acinar cells: Mediation by nonoxidative fatty acid metabolitesProceedings of the National Academy of Sciences, 2004